Skip to main content
SpringerLink
Log in

Non-Insulin-Dependent Diabetes and Contrast Media

  • Chapter
Contrast Media

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

In the 1990s, there was anxiety about the risk of lactic acidosis if intravascular iodinated contrast media caused nephrotoxicity in non-insulin-dependent diabetic patients on metformin. Guidelines from the European Society of Urogenital Radiology (ESUR) published in 1999 indicated that metformin administration should be stopped from the time of contrast medium administration for 48 h and only restarted when serum creatinine had been shown to be normal ( Thomsen et al. 1999). Since 1999, new data on the risk of metformin-associated lactic acidosis have become available and clinical practice for prescribing metformin to diabetic patients with impaired renal function has changed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bailey CJ, Turner RC (1996) Metformin. New Engl J Med 334:574–579

    Article  PubMed  CAS  Google Scholar 

  • Bettman MA (2002) Use of intravenous contrast agents in patients receiving metformin. Radiology 225:311–312

    Article  Google Scholar 

  • Balen AH, Rutherford AJ (2007) Managing anovulatory infertility and polycystic ovary syndrome. BMJ 335:663–666

    Article  PubMed  Google Scholar 

  • Bolen S, Feldman L, Vassy J et al. (2007) Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes. Ann Intern Med 147:386–399

    PubMed  Google Scholar 

  • Cherryman G, Campbell S, Crozier A et al (1998) Diabetics on metformin. Clin Radiol 53:465

    Article  PubMed  CAS  Google Scholar 

  • Cryer DR, Nicholas SP, Henry DH et al (2005) Comparative outcomes study of metformin intervention versus conventional approach the COSMIC approach study. Diabet Care 28:539–543

    Article  CAS  Google Scholar 

  • Dachman AH (1995) New contraindication to intravascular iodinated contrast material. Radiology 197:545

    PubMed  CAS  Google Scholar 

  • Duddy MJ (1998) Metformin and contrast: the risk. Clin Radiol 53:310

    Article  PubMed  CAS  Google Scholar 

  • Dunn CJ, Peters DH (1995) Metformin. A review of its pharmacological properties and therapeutic use in non-insulindependent diabetes mellitus. Drugs 49:721–749

    Article  PubMed  CAS  Google Scholar 

  • Fontsere N, Salinas I, Bonal J et al (2006) Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients? Nephrol Dial Transplant 21:2152–2158

    Article  PubMed  Google Scholar 

  • Holstein A, Stumvoll M (2005) Contraindications can damage your health- is metformin a case in point? Diabetologia 48:2454–2459

    Article  PubMed  CAS  Google Scholar 

  • Legro RS, Barnhart HX, Schlaff WD et al (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356:551–566

    Article  PubMed  CAS  Google Scholar 

  • Lord JM (2003) Insulin-sensitising drugs (metformin, troglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 2:CD 003053

    Google Scholar 

  • McCartney MM, Gilbert FJ, Murchison LE et al (1999) Metformin and contrast media — a dangerous combination? Clin Rad 54:29–33

    Article  CAS  Google Scholar 

  • McCullough PA, Adam A, Becker CR et al (2006) Risk prediction of contrast-induced nephropathy. Am J Cardiol 98(Suppl):27K–36K

    Article  PubMed  Google Scholar 

  • Middleton RJ, Foley RN, Hegarty J et al (2006) The unrecognised prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant 21:88–92

    Article  PubMed  Google Scholar 

  • Nawaz S, Cleveland T, Gaines PA, Chan P (1998) Clinical risk associated with contrast angiography in metformin treated patients: a clinical review. Clin Radiol 53:342–344

    Article  PubMed  CAS  Google Scholar 

  • New JP, Middleton RJ, Klebe B et al (2007) Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med 24:364–369

    Article  PubMed  CAS  Google Scholar 

  • Parfrey PS, Griffi SM, Barrett BJ et al (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency or both. New Engl J Med 320:143–149

    PubMed  CAS  Google Scholar 

  • Rachmani R, Slavachevski I, Levi Z et al (2002) Metformin in patients with type 2 diabetes: reconsideration of traditional contraindications. Eur J Int Med 13:428–433

    Article  CAS  Google Scholar 

  • Rasuli P, French G, Hammond DI (1996) New contraindication to intravascular contrast material. Radiology 201:289

    PubMed  CAS  Google Scholar 

  • Rasuli P, French GJ, Hammond DI (1998) Metformin hydrochloride all right before, but not after, contrast medium administration. Radiology 209:586–587

    PubMed  CAS  Google Scholar 

  • Rotter A (1995) New contraindication to intravascular iodinated contrast material. Radiology 197:545–546

    PubMed  CAS  Google Scholar 

  • Royal College of Radiologists (2005) Royal College of Radiologists Guidelines. Royal College of Radiologists, London

    Google Scholar 

  • Rudnick MR, Goldfarb S, Wexler L et al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomised trial. Kidney Int 47:254–261

    Article  PubMed  CAS  Google Scholar 

  • Sambol NC, Chiang J, Lin ET et al (1995) Kidney function and age are both predictors of pharmacokinetics of metformin. J Clin Pharmacol 35:1094–1102

    PubMed  CAS  Google Scholar 

  • Salpeter S, Greyber E, Pasternak G, Salpeter E (2006) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 25(1):CD 002967

    Google Scholar 

  • Shaw JS, Wilmot RL, Kilpatrick ES (2007) Establishing pragmatic estimated GFR thresholds to guide metformin prescribing. Diabet Med 24:1160–1163

    Article  PubMed  CAS  Google Scholar 

  • Sirtori CR, Pasik C (1994) Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 30:187–228

    Article  PubMed  CAS  Google Scholar 

  • Thomsen HS (2004) Gadolinium-based contrast media may be nephrotoxic even at approved doses (case report) Eur Radiol 15:749–754

    Google Scholar 

  • Thomsen HS (2006) Non-insulin dependent diabetes and contrast media. In: Thomsen HS (ed) Contrast media: safety issues and ESUR guidelines. Springer, Berlin

    Chapter  Google Scholar 

  • Thomsen HS, Morcos SK, ESUR Contrast Media Safety Committee (1999) Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. Eur Radiol 9:738–740

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, St Bartholomew’s Hospital, West Smithfield, London, EC1A 7BE, UK

    Judith A. W. Webb

Authors
  1. Judith A. W. Webb
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Diagnostic Radiology, Copenhagen University Hospital, Herlev

    Henrik S. Thomsen MD (Professor of Radiology Consultant, Director) (Professor of Radiology Consultant, Director)

  2. Department of Diagnostic Sciences Faculty of Health Sciences, University of Copenhagen, Herlev Ringvej 75, 2730, Herlev, Denmark

    Henrik S. Thomsen MD (Professor of Radiology Consultant, Director) (Professor of Radiology Consultant, Director)

  3. Department of Radiology St. Bartholomew’s Hospital, University of London, West Smithfield, London, EC1A 7BE, UK

    Judith A. W. Webb MD, FRCP, FRCR (Consultant (retired) (Consultant (retired)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Webb, J.A.W. (2009). Non-Insulin-Dependent Diabetes and Contrast Media. In: Thomsen, H.S., Webb, J.A.W. (eds) Contrast Media. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-72784-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-72784-2_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-72783-5

  • Online ISBN: 978-3-540-72784-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation